Medtronic Revenue 2010-2025 | MDT
Medtronic annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Medtronic revenue for the quarter ending April 30, 2025 was $8.927B, a 3.94% increase year-over-year.
- Medtronic revenue for the twelve months ending April 30, 2025 was $33.537B, a 3.62% increase year-over-year.
- Medtronic annual revenue for 2025 was $33.537B, a 3.62% increase from 2024.
- Medtronic annual revenue for 2024 was $32.364B, a 3.64% increase from 2023.
- Medtronic annual revenue for 2023 was $31.227B, a 1.45% decline from 2022.
| Medtronic Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $33,537 |
| 2024 | $32,364 |
| 2023 | $31,227 |
| 2022 | $31,686 |
| 2021 | $30,117 |
| 2020 | $28,913 |
| 2019 | $30,557 |
| 2018 | $29,953 |
| 2017 | $29,710 |
| 2016 | $28,833 |
| 2015 | $20,261 |
| 2014 | $17,005 |
| 2013 | $16,590 |
| 2012 | $16,184 |
| 2011 | $15,508 |
| 2010 | $15,392 |
| 2009 | $14,599 |
| Medtronic Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-04-30 | $8,927 |
| 2025-01-31 | $8,292 |
| 2024-10-31 | $8,403 |
| 2024-07-31 | $7,915 |
| 2024-04-30 | $8,589 |
| 2024-01-31 | $8,089 |
| 2023-10-31 | $7,984 |
| 2023-07-31 | $7,702 |
| 2023-04-30 | $8,544 |
| 2023-01-31 | $7,727 |
| 2022-10-31 | $7,585 |
| 2022-07-31 | $7,371 |
| 2022-04-30 | $8,089 |
| 2022-01-31 | $7,763 |
| 2021-10-31 | $7,847 |
| 2021-07-31 | $7,987 |
| 2021-04-30 | $8,188 |
| 2021-01-31 | $7,775 |
| 2020-10-31 | $7,647 |
| 2020-07-31 | $6,507 |
| 2020-04-30 | $5,997 |
| 2020-01-31 | $7,717 |
| 2019-10-31 | $7,706 |
| 2019-07-31 | $7,493 |
| 2019-04-30 | $8,146 |
| 2019-01-31 | $7,546 |
| 2018-10-31 | $7,481 |
| 2018-07-31 | $7,384 |
| 2018-04-30 | $8,144 |
| 2018-01-31 | $7,369 |
| 2017-10-31 | $7,050 |
| 2017-07-31 | $7,390 |
| 2017-04-30 | $7,916 |
| 2017-01-31 | $7,283 |
| 2016-10-31 | $7,345 |
| 2016-07-31 | $7,166 |
| 2016-04-30 | $7,567 |
| 2016-01-31 | $6,934 |
| 2015-10-31 | $7,058 |
| 2015-07-31 | $7,274 |
| 2015-04-30 | $7,304 |
| 2015-01-31 | $4,318 |
| 2014-10-31 | $4,366 |
| 2014-07-31 | $4,273 |
| 2014-04-30 | $4,565 |
| 2014-01-31 | $4,163 |
| 2013-10-31 | $4,194 |
| 2013-07-31 | $4,083 |
| 2013-04-30 | $4,460 |
| 2013-01-31 | $4,027 |
| 2012-10-31 | $4,095 |
| 2012-07-31 | $4,008 |
| 2012-04-30 | $4,297 |
| 2012-01-31 | $3,918 |
| 2011-10-31 | $4,023 |
| 2011-07-31 | $3,946 |
| 2011-04-30 | $3,975 |
| 2011-01-31 | $3,857 |
| 2010-10-31 | $3,903 |
| 2010-07-31 | $3,773 |
| 2010-04-30 | $3,770 |
| 2010-01-31 | $3,851 |
| 2009-10-31 | $3,838 |
| 2009-07-31 | $3,933 |
| 2009-04-30 | $3,829 |
| 2009-01-31 | $3,494 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $113.364B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |